PlushCare connects patients with branded GLP-1 prescriptions through external pharmacies, but medication costs vary widely. Seven telehealth competitors offer compounded GLP-1s at fixed all-in rates—we compare verified pricing, service models, and 12-month costs.

Hims & Hers charges $199/month for compounded semaglutide but requires $1,194 paid upfront for six months. Seven verified alternatives offer month-to-month plans, lower per-month rates, or tirzepatide options Hims & Hers doesn't yet publish.

Found offers insurance and annual-prepay options, but month-to-month semaglutide runs $289 ($313 effective with Found's 13-charge-per-year billing). Seven verified alternatives with transparent cash pricing, some at substantially lower recurring rates.

Form Health charges $299/month for physician and dietitian care, with medication and labs billed separately. Nine compounded-GLP-1 alternatives deliver all-in pricing from $129 to $359/month, verified at checkout.

AltRx's promotional rates expire September 5, 2026; post-promotional pricing is undocumented. We compare advertised costs, billing-practice reports, and service stability for readers considering a switch.

Eden's two-charge membership model costs $198/month for semaglutide, while PlexusDx delivers the same compound for $189/month with no separate fee. This breakdown compares structure, all-in pricing, format options, and cancellation terms for patients considering the switch.

Henry Meds month-to-month injectable semaglutide costs $297; PlexusDx costs $189 for the same compound and route. If you need tirzepatide or prefer no prepay commitment, the case for switching is straightforward. If you're on Henry Meds oral semaglutide at $249, the economics reverse.

OrderlyMeds offers lower semaglutide pricing, but PlexusDx provides clearer ongoing rates and stronger support ratings. This comparison uses verified pricing, review data, and 12-month cost calculations to help you decide whether switching makes sense.

Mochi Health's per-dose pricing starts lower but rises as you titrate; PlexusDx charges the same flat rate at every dose. Here's what changes when you switch.

Zealthy advertises compounded semaglutide from $151 monthly when purchased quarterly, but that rate is unverified and the membership fee remains unclear. We compare seven checkout-verified cash-pay GLP-1 alternatives with transparent monthly costs and no prepayment requirement.

Eden charges $198–$298/month all-in with a two-bill structure and money-back pledge. Six checkout-verified alternatives range from $189–$399/month with different billing models, format options, and commitment tiers.

Henry Meds sells sublingual semaglutide tablets at $249/month month-to-month. Several alternatives—PlexusDx, Eden, Peak Wellness, Embody, and others—offer oral or sublingual formats between $198 and $349/month.

Mochi Health's per-dose model starts at $60 semaglutide or $90 tirzepatide plus membership, but costs rise with higher doses. We compare seven flat-rate programs that hold one price across all dose levels.

Remedy Meds microdose plans start at $189/month but require completing an intake quiz to see pricing. PlexusDx publishes microdose pricing at $129/month upfront, a $720 annual difference on comparable month-to-month plans.

Zealthy advertises compounded semaglutide at a quarterly prepaid rate, but critical details—quarterly upfront total, membership fees, and verified customer reviews—remain undisclosed in public documentation, making a complete value judgment impossible without checkout verification.

Henry Meds charges $297/month for injectable semaglutide with no membership fee and offers prepaid discounts, but reported service complaints and inconsistent product labeling raise questions about whether the upfront savings justify the potential operational risk.

10Rx advertises $99.67/month semaglutide and $150/month tirzepatide as prepaid quarterly equivalents. We verified the pricing structure, examined the pharmacy disclosures, searched for independent reviews, and compared the quarterly prepay model to month-to-month alternatives.

Only three national programs deliver compounded semaglutide at or below $150 per month, and each comes with documented trade-offs in contract terms, service reliability, or dose policy. This evidence-based roundup compares verified pricing, service records, and hidden costs captured September 2026.

Fifty410 charges $199/month for semaglutide and $399–$549 upfront for tirzepatide (3-month bundles). GobyMeds charges $299–$499 upfront for semaglutide (3-month bundles, dose-tiered) and $299/month for tirzepatide. We break down starter versus high-dose costs over 12 months.

Found's 12-month cash-pay semaglutide plan requires $2,028 upfront for a $169/month rate; Hims & Hers advertises $199/month with a 6-month $1,194 commitment. PlexusDx offers $189 month-to-month with no prepayment. Here's how the economics and service models compare.

BrightMeds offers compounded GLP-1 injections starting at $129/month with a 4.8-star Trustpilot rating and over 900 reviews, but pharmacy partner details remain undisclosed.

MEDVi is an operating telehealth platform with a published address, named compounding pharmacies, and a posted refund policy, but legitimacy and fit are different questions. This page separates provider licensure, pharmacy licensure, FDA status, pricing terms, and customer feedback, and gives you a checklist to verify before enrolling.

Eden holds a 4.5-star Trustpilot rating across roughly 5,000 reviews, but some customers report 11-day order delays and repeated support requests for records already issued.

Henry Meds holds a 4.4-star Trustpilot rating across ~13,000 reviews, charges $297/month for injectable semaglutide, and requires prepaid plan balance payment on early cancellation unless medically necessary.

Found bundles GLP-1 prescriptions with 24/7 coaching and an AI assistant. How do its membership features, medication options, and cancellation terms compare to cash-pay alternatives in 2026?

Found offers separate insurance and cash-pay tracks for GLP-1 weight management. We compare the program fees, medication costs, prepay economics, and coverage models—measured against checkout-verified evidence captured September 4, 2026.

Willow charges $299/month for semaglutide and $399 for tirzepatide; Henry Meds quotes $297 injectable and $249 oral semaglutide month-to-month. PlexusDx injectable semaglutide runs $189/month with no membership. We compare plans, routes, prepay terms, and 12-month costs using September 2026 pricing.

OrderlyMeds leads with a two-month starter promotion, Fridays offers prepaid multi-month tiers, and PlexusDx publishes fixed month-to-month rates. We compare pricing structures, upfront commitments, and twelve-month effective costs for compounded semaglutide and tirzepatide.

Henry Meds charges $297/month for compounded semaglutide injection month-to-month; Mochi Health advertises a first-month rate that rises with dose escalation using per-dose pricing. We compare all-in costs, plan structures, and medication routes for both providers.

MEDVi and Remedy Meds both open with a lower first payment and then move to a higher recurring refill for compounded semaglutide injection. This post isolates the first-to-second-bill transition, shows matched billing-cycle totals, and lists what to confirm before either offer renews.